BioSpace News Archive

Business

Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-Monitoring Device

Teijin Pharmaand SRETT announced today they have agreed to an exclusive distribution arrangement in Japan for TeleOx, a device developed by SRETT which remotely monitors patient’s respiratory functions　in oxygen therapy.

November 16, 2017

·

3 min read

Biotech Beach

SoCal’s Modulated Imaging Closes $2.86M Series A Funding Round

This represents the medical device company’s second financing round since July of last year.

November 16, 2017

·

4 min read

Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

The funds will be used to grow the Company’s catalogue of off-the-shelf human cell type products and expand its service offerings, marking its first step towards more complex products, including human organ-on-chip models, and cell-based therapies.

November 16, 2017

·

3 min read

Business

Guardant Health Expands Support for the Development of the GuardantOMNI Assay Through New Agreement With Bristol-Myers Squibb

Guardant Health has added BMS to the group of pharmaceutical companies it is working with to develop the GuardantOMNI assay, a 500-plus-gene liquid biopsy panel designed to accelerate clinical trials and the research of targeted cancer drugs and immunotherapies.

November 16, 2017

·

2 min read

Business

Nephron Pharma Continues Efforts to Solve Drug Shortage Crisis by Increasing Production and Expanding Capacity

Nephron officials recognize that persistent drug shortages pose a threat to the quality of patient care as discussed in the ASHP letter entitled “Healthcare Groups Urge Congressional Action on Drug Shortages.”

November 16, 2017

·

2 min read

AxoGen Announces Pricing of Public Offering of Common Stock

The offering consists of 700,000 shares being sold by AxoGen and 1,000,000 shares being sold by EW Healthcare Partners L.P.

November 16, 2017

·

4 min read

Drug Development

Onconova Therapeutics Announces Data on Improved Formulation of Rigosertib and Next-Generation CDK4/6 Inhibitor at 2017 American Association of Pharmaceutical Scientists Annual Meeting

Three posters were presented at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world’s largest pharmaceutical sciences meeting, during November 14-15, 2017.

November 16, 2017

·

7 min read

Drug Development

Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase I/II Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

Initial data from this first cohort of three patients is expected in early 2018.

November 16, 2017

·

4 min read

Drug Development

BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer

Patients are being followed for up to 2 years, and the median follow-up at the time of the analysis is approximately 18 months.

November 16, 2017

·

5 min read

Drug Development

Stemline Therapeutics Announces Oral Presentation of SL-701 Phase II Data in Second-Line Glioblastoma at the 22nd Annual Meeting of the Society of Neuro-Oncology (SNO)

The conference is being held November 16-19, 2017 in San Francisco, CA.

November 16, 2017

·

4 min read